Update: March 27, 2022
biony (Headquarters: Shibuya-ku, Tokyo, Japan) has been selected by Microsoft Corporation (Headquarters: Washington, USA, Microsoft Corporation) for its "Microsoft for Startups" program.
biomy provides drug discovery support through digital technologies such as AI/IT. We are engaged in discovery of drug targets, prediction of drug efficacy, and research and development of digital therapeutic technologies based on big data.
As a result of being selected for "Microsoft for Startups," we will promote the technological development of AI and Big Data analysis platform, jointly promote and announce R&D achievements with Microsoft.
We aim to develop new services and partners by collaborating with companies using Azure, discover partner companies by accessing our global network, and release services outside of Japan.
